Buy Celexa from Discount Pharmacy
We are a leading Canadian mail-order pharmacy service focusing on both on prescription cost-containment and patient safety. We only work with a small network of trusted and reputable international pharmacies and fulfillment centers, giving you access to authentic medications at low prices every day. All medications are shipped directly to you from our affiliated licensed international and Canadian pharmacies and fulfillment centers. Our staff are knowledgeable and efficient to ensure that your shopping experience is hassle free. Save on prescription drugs like Celexa as well as other prescription drugs like Avodart, Casodex, Cymbalta, Gleevec, Nuvigil, Plavix, Provigil, Singulair, Topamax, Wellbutrin XL.
10 Great Reasons to Choose Our Service!
Your Celexa are shipped in sealed drug manufacturer's containers from the licensed pharmacy.
Convenient and simple Canadian discount prescription service that delivers right to your home. No more cross the border shopping.
Medications ordered in Canada from our Canadian pharmacy are non-taxable.
Live and friendly customer service staff available 5 days a week ready to help your questions or assist you in ordering.
The exchange rate between the American currency and Canadian dollar allows American more spending power when buying from Canada.
A licensed and accredited pharmacy will dispense and fill your prescription drugs from your chosen pharmacy.
Our 24 hour toll-free fax number provides a simple, quick and easy way to place your order.
All Canadian prescription drugs have been approved for sale by Health Canada, the Canadian FDA equivalent.
Our Prescription medications are available at unbelievable discounts compared to US based pharmacies.
The international Generic Program may have the generic version of Celexa saving your further money.
Why Are Cancer Drugs So Expensive?
The high cost of cancer drugs is related to a number of factors. It is very very expensive to move findings from bench to bedside and to perform all the regulatory studies (from phase 1, 2, and 3 clinical trials) to gain approval. Second, even when the monopoly is broken with the arrival of 'new and improved' versions of an approved drug, the older drug (and by now generic) tends to be viewed as substandard treatment, thereby perpetuating the situation. Third, the very nature of cancer, and the seriousness of the diagnosis, plays a role in that patients and physicians are often willing to pay the high price of treatment even for marginal improvements in outcome. Finally, because most cancers are incurable, patients are treated with each approved agent creating a virtual monopoly because the use of one drug does not automatically mean that the others are no longer needed.